Site-less trials promise to speed up drug development — but obstacles to in-home data collection abound.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Nutzenbewertung digitaler Gesundheitsanwendungen – Herausforderungen und Möglichkeiten
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz Open Access 15 September 2021
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
Purchase on Springer Link
Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Dolgin, E. Industry embraces virtual trial platforms. Nat Rev Drug Discov 17, 305–306 (2018). https://doi.org/10.1038/nrd.2018.66
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd.2018.66
This article is cited by
-
Nutzenbewertung digitaler Gesundheitsanwendungen – Herausforderungen und Möglichkeiten
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz (2021)